DEL BELLO, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.988
EU - Europa 4.347
AS - Asia 2.152
SA - Sud America 57
Continente sconosciuto - Info sul continente non disponibili 43
AF - Africa 18
OC - Oceania 14
Totale 15.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.701
CN - Cina 1.519
IT - Italia 1.181
DE - Germania 775
PL - Polonia 643
UA - Ucraina 352
SG - Singapore 314
SE - Svezia 293
CA - Canada 278
GB - Regno Unito 226
FI - Finlandia 218
RU - Federazione Russa 173
FR - Francia 155
TR - Turchia 116
IE - Irlanda 107
CZ - Repubblica Ceca 70
BE - Belgio 51
IN - India 40
EU - Europa 38
VN - Vietnam 34
BR - Brasile 31
NL - Olanda 26
PK - Pakistan 22
IR - Iran 20
JP - Giappone 15
AU - Australia 14
EG - Egitto 13
KR - Corea 13
HK - Hong Kong 11
HR - Croazia 11
MY - Malesia 10
PT - Portogallo 10
RO - Romania 10
UY - Uruguay 9
GR - Grecia 8
BY - Bielorussia 7
MX - Messico 7
PE - Perù 7
AT - Austria 6
ID - Indonesia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
CL - Cile 4
IQ - Iraq 4
CH - Svizzera 3
CO - Colombia 3
DK - Danimarca 3
HU - Ungheria 3
KG - Kirghizistan 3
RS - Serbia 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DZ - Algeria 2
IL - Israele 2
IS - Islanda 2
KH - Cambogia 2
LT - Lituania 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
AL - Albania 1
AR - Argentina 1
BO - Bolivia 1
BS - Bahamas 1
EE - Estonia 1
ES - Italia 1
GE - Georgia 1
JM - Giamaica 1
LK - Sri Lanka 1
NP - Nepal 1
PS - Palestinian Territory 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 15.619
Salva come PNG Salva come JPEG
Città #
Fairfield 925
Jacksonville 863
Woodbridge 819
Chandler 602
Ashburn 548
Warsaw 525
Ann Arbor 517
Houston 502
Wilmington 458
Boardman 425
Seattle 362
Camerino 311
Cambridge 292
Nanjing 275
Toronto 222
Singapore 218
Dearborn 203
Beijing 153
San Mateo 140
Lawrence 130
Princeton 129
Helsinki 125
Kraków 113
Dublin 107
Nanchang 103
Istanbul 101
Columbus 97
Ogden 96
Düsseldorf 83
Shanghai 72
New York 68
London 66
Shenyang 66
Jiaxing 57
Kunming 57
Brno 56
Guangzhou 55
Moscow 53
Lachine 50
Los Angeles 48
Jinan 47
Brussels 44
San Diego 44
Tianjin 43
Milan 40
Hebei 39
Munich 39
Bremen 38
Changsha 37
Centro 36
Philadelphia 31
Dong Ket 29
Redwood City 27
Zhengzhou 27
Wuhan 26
Venezia 25
Hangzhou 24
Ningbo 24
Hefei 22
Leawood 21
Perugia 21
Falls Church 19
Monmouth Junction 19
Taizhou 18
Chicago 17
Orange 17
Nantong 16
Nürnberg 16
Pesaro 15
Venice 15
Washington 15
Buffalo 14
Jinhua 14
Tulsa 14
Rome 13
Verona 13
Changchun 12
Kocaeli 12
Lanzhou 12
Norwalk 12
Olomouc 12
Fuzhou 11
Lahore 11
Strasbourg 11
Tappahannock 11
Yiwu 11
Ancona 10
Ardabil 10
Auburn Hills 10
Binzhou 10
Buti 10
Council Bluffs 10
Macerata 10
Old Bridge 10
West Jordan 10
Augusta 9
Baotou 9
Montevideo 9
Chongqing 8
Dronten 8
Totale 11.259
Salva come PNG Salva come JPEG
Nome #
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 269
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 266
An Efficient Lewis Acid Catalyzed Povarov Reaction for the One-Pot Stereocontrolled Synthesis of Polyfunctionalized Tetrahydroquinolines 259
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 250
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 246
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation 241
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 237
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 236
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine 234
Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring 230
Exploring the Role of N6‐Substituents in Potent Dual Acting 5'‐C‐Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 228
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 211
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 210
1,4-Dioxane Nucleus as a Suitable Scaffold for the Characterization of Different Receptor Systems 207
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 206
1,4-Dioxane nucleus as a suitable scaffold in the building of ligands interacting with NMDA and σ1 receptors 200
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 199
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 196
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 194
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 185
Investigation of allyphenyline efficacy in the treatment of alcohol withdrawal symptoms 175
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 174
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 173
Structure-Based Design, Synthesis and in vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists 169
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 167
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 165
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 163
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 159
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 159
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 157
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 156
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats 154
Effects of imidazoline I2 receptor ligands on acute nociception in rats 150
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 150
Synthesis and Biological Evaluation of a Novel Series of Heterobivalent Muscarinic Ligands Based on Xanomeline and 1‑[3- (4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77- LH-28-1) 149
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 149
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 148
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 148
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 142
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 141
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 141
From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: synthesis and biological evaluation of valproic esters of 3'-C-methyladenosine 140
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma 139
Synthesis of Triazole-Linked Analogues of c‐di-GMP and Their Interactions with Diguanylate Cyclase 139
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 137
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 136
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 133
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 132
null 132
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 131
null 129
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 128
Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility 128
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 126
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 126
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 122
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 120
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 120
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 117
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 115
Adenosine receptors as promising targets for the management of ocular diseases 115
New insights in Au-NHCs complexes as anticancer agents 114
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 111
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 111
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 111
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 111
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 110
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 109
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 106
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 105
Trekking through receptor chemistry 103
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 103
Effects of allyphenyline on chronic alcohol intoxication model 102
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 102
Imidazoline nucleus as a biologically versatile scaffold 101
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 100
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 98
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 98
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 97
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 96
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 96
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 95
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 94
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 93
Aminopyrimidines as inhibitors of the Wnt signalling pathway 92
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 91
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 91
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 91
4WD to Travel Inside the 5-HT1A Receptor World 91
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 89
Might the observed alpha2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 88
Activation of primary amines by copper(I)-based Lewis acid promoters in the solventless synthesis of secondary propargylamines 87
Structural motives of imidazoline molecules favouring the serotonin 5-HT1A receptor activation 85
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 85
Alpha2C-adrenoceptor modulators: a patent review 81
Novel α1-adrenoreceptor antagonists related to openphendioxan: biological evaluation and α1d computational study 80
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives 78
Design, synthesis, reactivity, biological and catalytic applications of functionalized bis(pyrazolyl)acetate copper complexes 77
Novel muscarinic antagonists designed on the 1,4-dioxane scaffold 76
Efficient Lewis Acid Systems for the A3 Coupling reaction 76
Totale 14.082
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.230 0 0 0 0 0 0 306 280 171 169 93 211
2020/20212.642 131 242 196 239 172 171 345 112 213 158 430 233
2021/20221.428 122 359 38 58 93 63 46 111 122 165 85 166
2022/20231.867 232 71 89 237 186 214 20 118 360 106 152 82
2023/20241.608 195 94 131 52 68 175 76 57 159 62 43 496
2024/20251.499 241 112 427 246 194 266 13 0 0 0 0 0
Totale 16.094